Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 137

    1.

    Assaying estrogenicity by quantitating the expression levels of endogenous estrogen-regulated genes.

    Jørgensen M, Vendelbo B, Skakkebaek NE, Leffers H.

    Environ Health Perspect. 2000 May;108(5):403-12.PMID: 10811566 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Oestrogenic potencies of Zeranol, oestradiol, diethylstilboestrol, Bisphenol-A and genistein: implications for exposure assessment of potential endocrine disrupters.

    Leffers H, Naesby M, Vendelbo B, Skakkebaek NE, Jørgensen M.

    Hum Reprod. 2001 May;16(5):1037-45.PMID: 11331657 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Amphibians as a model to study endocrine disruptors: II. Estrogenic activity of environmental chemicals in vitro and in vivo.

    Kloas W, Lutz I, Einspanier R.

    Sci Total Environ. 1999 Jan 12;225(1-2):59-68.PMID: 10028703 [PubMed - indexed for MEDLINE]Related articles

    4.

    Relative binding affinity does not predict biological response to xenoestrogens in rat endometrial adenocarcinoma cells.

    Strunck E, Stemmann N, Hopert A, Wünsche W, Frank K, Vollmer G.

    J Steroid Biochem Mol Biol. 2000 Oct;74(3):73-81.PMID: 11086226 [PubMed - indexed for MEDLINE]Related articles

    5.

    Comparison of short-term estrogenicity tests for identification of hormone-disrupting chemicals.

    Andersen HR, Andersson AM, Arnold SF, Autrup H, Barfoed M, Beresford NA, Bjerregaard P, Christiansen LB, Gissel B, Hummel R, Jørgensen EB, Korsgaard B, Le Guevel R, Leffers H, McLachlan J, Møller A, Nielsen JB, Olea N, Oles-Karasko A, Pakdel F, Pedersen KL, Perez P, Skakkeboek NE, Sonnenschein C, Soto AM, et al.

    Environ Health Perspect. 1999 Feb;107 Suppl 1:89-108.PMID: 10229711 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Sulfation of bisphenol A abolished its estrogenicity based on proliferation and gene expression in human breast cancer MCF-7 cells.

    Shimizu M, Ohta K, Matsumoto Y, Fukuoka M, Ohno Y, Ozawa S.

    Toxicol In Vitro. 2002 Oct;16(5):549-56.PMID: 12206822 [PubMed - indexed for MEDLINE]Related articles

    8.

    Using a customized DNA microarray for expression profiling of the estrogen-responsive genes to evaluate estrogen activity among natural estrogens and industrial chemicals.

    Terasaka S, Aita Y, Inoue A, Hayashi S, Nishigaki M, Aoyagi K, Sasaki H, Wada-Kiyama Y, Sakuma Y, Akaba S, Tanaka J, Sone H, Yonemoto J, Tanji M, Kiyama R.

    Environ Health Perspect. 2004 May;112(7):773-81.PMID: 15159206 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Estrogenic effects of environmental chemicals: an interspecies comparison.

    Olsen CM, Meussen-Elholm ET, Hongslo JK, Stenersen J, Tollefsen KE.

    Comp Biochem Physiol C Toxicol Pharmacol. 2005 Jul;141(3):267-74.PMID: 16099220 [PubMed - indexed for MEDLINE]Related articles

    10.

    Co-culture of primary human mammary fibroblasts and MCF-7 cells as an in vitro breast cancer model.

    Heneweer M, Muusse M, Dingemans M, de Jong PC, van den Berg M, Sanderson JT.

    Toxicol Sci. 2005 Feb;83(2):257-63. Epub 2004 Nov 3.PMID: 15525692 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Assessing estrogenic activity of pyrethroid insecticides using in vitro combination assays.

    Kim IY, Shin JH, Kim HS, Lee SJ, Kang IH, Kim TS, Moon HJ, Choi KS, Moon A, Han SY.

    J Reprod Dev. 2004 Apr;50(2):245-55.PMID: 15118252 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Stimulation of calbindin-D(9k) mRNA expression in the rat uterus by octyl-phenol, nonylphenol and bisphenol.

    An BS, Kang SK, Shin JH, Jeung EB.

    Mol Cell Endocrinol. 2002 Jun 14;191(2):177-86.PMID: 12062901 [PubMed - indexed for MEDLINE]Related articles

    14.

    Estrogenicity of organophosphorus and pyrethroid pesticides.

    Chen H, Xiao J, Hu G, Zhou J, Xiao H, Wang X.

    J Toxicol Environ Health A. 2002 Oct 11;65(19):1419-35.PMID: 12396874 [PubMed - indexed for MEDLINE]Related articles

    15.

    Mixture effects of estrogenic compounds on proliferation and pS2 expression of MCF-7 human breast cancer cells.

    van Meeuwen JA, Ter Burg W, Piersma AH, van den Berg M, Sanderson JT.

    Food Chem Toxicol. 2007 Nov;45(11):2319-30. Epub 2007 Jun 15.PMID: 17651883 [PubMed - indexed for MEDLINE]Related articles

    16.

    Long-term hydroxytamoxifen treatment of an MCF-7-derived breast cancer cell line irreversibly inhibits the expression of estrogenic genes through chromatin remodeling.

    Badia E, Duchesne MJ, Semlali A, Fuentes M, Giamarchi C, Richard-Foy H, Nicolas JC, Pons M.

    Cancer Res. 2000 Aug 1;60(15):4130-8.PMID: 10945620 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Induction of aromatase (CYP19) expression in breast cancer cells through a nongenomic action of estrogen receptor alpha.

    Kinoshita Y, Chen S.

    Cancer Res. 2003 Jul 1;63(13):3546-55.PMID: 12839940 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Keratinocyte growth factor (KGF) induces tamoxifen (Tam) resistance in human breast cancer MCF-7 cells.

    Chang HL, Sugimoto Y, Liu S, Ye W, Wang LS, Huang YW, Lin YC.

    Anticancer Res. 2006 May-Jun;26(3A):1773-84.PMID: 16827106 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data